Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve This is to intimate ....
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Wednesday, 13 August 2025. The main item on the agenda is to consider and approve the Unaudited Financial Results along with the Limited Review Report for Q1 FY26 (quarter ended 30 June 2025). Any other business may be taken up with the Chairman's consent. The company's trading window for insiders has been closed since 1 July 2025 and will remain closed until 48 hours after the results are announced.
This is a routine pre-results announcement — no immediate impact on shareholders. Investors should watch for the Q1 FY26 results on or shortly after 13 August for actual financial performance.